Pediatric cardiomyopathy as a chronic disease: A perspective on comprehensive care programs

Natalya Bublik, Jorge A. Alvarez, Steven E Lipshultz

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Substantial numbers of children with cardiomyopathy are now surviving into adulthood, making it essentially a chronic disease. As a chronic condition, it may be best treated through comprehensive, multidisciplinary treatment programs. Such programs have improved health outcomes and reduced costs in managing other pediatric chronic diseases and heart failure in adults, but the treatment and cost implications of programs for managing pediatric cardiomyopathy are unknown. We investigated the treatment and cost implications of establishing such programs by reviewing cost-effectiveness studies of similar programs, estimating the current inpatient costs of this diagnosis, and interviewing experts in the field about the need and desirability of these programs. According to our findings, comprehensive pediatric heart failure programs do exist, but they have not been evaluated or even described in the literature. Consensus among experts in the field is that comprehensive chronic care programs are highly desirable, and similar programs have reported tremendous cost savings through early and intensive management: the return on investment has been as high as 22 to 1. Another study reported that mean length of stay decreased from 83.9 to 10.6 days, mean annual admissions decreased from 2796 to 1622, and median hospital charges decreased from $26.1 million to $14.6 million. In conclusion, limited experience and strong circumstantial evidence suggest that, despite substantial costs, comprehensive multidisciplinary pediatric heart failure programs would be cost-effective and beneficial to patients, families, and institutions alike.

Original languageEnglish
Pages (from-to)103-111
Number of pages9
JournalProgress in Pediatric Cardiology
Volume25
Issue number1
DOIs
StatePublished - Apr 1 2008

Fingerprint

Cardiomyopathies
Chronic Disease
Pediatrics
Costs and Cost Analysis
Heart Failure
Health Care Costs
Hospital Charges
Cost Savings
Cost-Benefit Analysis
Inpatients
Length of Stay
Consensus
Health
Therapeutics

Keywords

  • Comprehensive programs
  • Multidisciplinary programs
  • Pediatric cardiomyopathy
  • Pediatric heart failure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Pediatric cardiomyopathy as a chronic disease : A perspective on comprehensive care programs. / Bublik, Natalya; Alvarez, Jorge A.; Lipshultz, Steven E.

In: Progress in Pediatric Cardiology, Vol. 25, No. 1, 01.04.2008, p. 103-111.

Research output: Contribution to journalArticle

Bublik, Natalya ; Alvarez, Jorge A. ; Lipshultz, Steven E. / Pediatric cardiomyopathy as a chronic disease : A perspective on comprehensive care programs. In: Progress in Pediatric Cardiology. 2008 ; Vol. 25, No. 1. pp. 103-111.
@article{ea46d5bb34ef4d119ba4a3444503b0fa,
title = "Pediatric cardiomyopathy as a chronic disease: A perspective on comprehensive care programs",
abstract = "Substantial numbers of children with cardiomyopathy are now surviving into adulthood, making it essentially a chronic disease. As a chronic condition, it may be best treated through comprehensive, multidisciplinary treatment programs. Such programs have improved health outcomes and reduced costs in managing other pediatric chronic diseases and heart failure in adults, but the treatment and cost implications of programs for managing pediatric cardiomyopathy are unknown. We investigated the treatment and cost implications of establishing such programs by reviewing cost-effectiveness studies of similar programs, estimating the current inpatient costs of this diagnosis, and interviewing experts in the field about the need and desirability of these programs. According to our findings, comprehensive pediatric heart failure programs do exist, but they have not been evaluated or even described in the literature. Consensus among experts in the field is that comprehensive chronic care programs are highly desirable, and similar programs have reported tremendous cost savings through early and intensive management: the return on investment has been as high as 22 to 1. Another study reported that mean length of stay decreased from 83.9 to 10.6 days, mean annual admissions decreased from 2796 to 1622, and median hospital charges decreased from $26.1 million to $14.6 million. In conclusion, limited experience and strong circumstantial evidence suggest that, despite substantial costs, comprehensive multidisciplinary pediatric heart failure programs would be cost-effective and beneficial to patients, families, and institutions alike.",
keywords = "Comprehensive programs, Multidisciplinary programs, Pediatric cardiomyopathy, Pediatric heart failure",
author = "Natalya Bublik and Alvarez, {Jorge A.} and Lipshultz, {Steven E}",
year = "2008",
month = "4",
day = "1",
doi = "10.1016/j.ppedcard.2007.11.011",
language = "English",
volume = "25",
pages = "103--111",
journal = "Progress in Pediatric Cardiology",
issn = "1058-9813",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Pediatric cardiomyopathy as a chronic disease

T2 - A perspective on comprehensive care programs

AU - Bublik, Natalya

AU - Alvarez, Jorge A.

AU - Lipshultz, Steven E

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Substantial numbers of children with cardiomyopathy are now surviving into adulthood, making it essentially a chronic disease. As a chronic condition, it may be best treated through comprehensive, multidisciplinary treatment programs. Such programs have improved health outcomes and reduced costs in managing other pediatric chronic diseases and heart failure in adults, but the treatment and cost implications of programs for managing pediatric cardiomyopathy are unknown. We investigated the treatment and cost implications of establishing such programs by reviewing cost-effectiveness studies of similar programs, estimating the current inpatient costs of this diagnosis, and interviewing experts in the field about the need and desirability of these programs. According to our findings, comprehensive pediatric heart failure programs do exist, but they have not been evaluated or even described in the literature. Consensus among experts in the field is that comprehensive chronic care programs are highly desirable, and similar programs have reported tremendous cost savings through early and intensive management: the return on investment has been as high as 22 to 1. Another study reported that mean length of stay decreased from 83.9 to 10.6 days, mean annual admissions decreased from 2796 to 1622, and median hospital charges decreased from $26.1 million to $14.6 million. In conclusion, limited experience and strong circumstantial evidence suggest that, despite substantial costs, comprehensive multidisciplinary pediatric heart failure programs would be cost-effective and beneficial to patients, families, and institutions alike.

AB - Substantial numbers of children with cardiomyopathy are now surviving into adulthood, making it essentially a chronic disease. As a chronic condition, it may be best treated through comprehensive, multidisciplinary treatment programs. Such programs have improved health outcomes and reduced costs in managing other pediatric chronic diseases and heart failure in adults, but the treatment and cost implications of programs for managing pediatric cardiomyopathy are unknown. We investigated the treatment and cost implications of establishing such programs by reviewing cost-effectiveness studies of similar programs, estimating the current inpatient costs of this diagnosis, and interviewing experts in the field about the need and desirability of these programs. According to our findings, comprehensive pediatric heart failure programs do exist, but they have not been evaluated or even described in the literature. Consensus among experts in the field is that comprehensive chronic care programs are highly desirable, and similar programs have reported tremendous cost savings through early and intensive management: the return on investment has been as high as 22 to 1. Another study reported that mean length of stay decreased from 83.9 to 10.6 days, mean annual admissions decreased from 2796 to 1622, and median hospital charges decreased from $26.1 million to $14.6 million. In conclusion, limited experience and strong circumstantial evidence suggest that, despite substantial costs, comprehensive multidisciplinary pediatric heart failure programs would be cost-effective and beneficial to patients, families, and institutions alike.

KW - Comprehensive programs

KW - Multidisciplinary programs

KW - Pediatric cardiomyopathy

KW - Pediatric heart failure

UR - http://www.scopus.com/inward/record.url?scp=40949084269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40949084269&partnerID=8YFLogxK

U2 - 10.1016/j.ppedcard.2007.11.011

DO - 10.1016/j.ppedcard.2007.11.011

M3 - Article

AN - SCOPUS:40949084269

VL - 25

SP - 103

EP - 111

JO - Progress in Pediatric Cardiology

JF - Progress in Pediatric Cardiology

SN - 1058-9813

IS - 1

ER -